Northern Trust Corp Cti Biopharma Corp Transaction History

Northern Trust Corp

  • $600 Billion
  • Q3 2024

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$4.2 - $6.01 $65,809 - $94,170
-15,669 Reduced 1.81%
847,737 $3.56 Million
Q4 2022

Feb 13, 2023
BUY
$4.45 - $6.17 $262,047 - $363,332
58,887 Added 7.32%
863,406 $5.19 Million
Q3 2022

Nov 14, 2022
BUY
$5.36 - $7.43 $263,176 - $364,813
49,100 Added 6.5%
804,519 $4.68 Million
Q2 2022

Aug 12, 2022
BUY
$3.55 - $6.27 $2.21 Million - $3.9 Million
621,234 Added 462.97%
755,419 $4.51 Million
Q1 2022

May 13, 2022
SELL
$1.9 - $5.23 $2,865 - $7,886
-1,508 Reduced 1.11%
134,185 $627,000
Q4 2021

Feb 08, 2022
BUY
$1.44 - $2.86 $13,584 - $26,981
9,434 Added 7.47%
135,693 $337,000
Q2 2021

Aug 13, 2021
BUY
$2.16 - $2.62 $55,092 - $66,825
25,506 Added 25.32%
126,259 $316,000
Q1 2021

May 12, 2021
BUY
$2.68 - $3.8 $7,069 - $10,024
2,638 Added 2.69%
100,753 $294,000
Q4 2020

Feb 11, 2021
SELL
$2.48 - $3.8 $15,591 - $23,890
-6,287 Reduced 6.02%
98,115 $316,000
Q3 2020

Nov 16, 2020
BUY
$1.02 - $2.15 $7,171 - $15,116
7,031 Added 7.22%
104,402 $224,000
Q2 2020

Aug 14, 2020
SELL
$0.88 - $1.32 $13,993 - $20,990
-15,902 Reduced 14.04%
97,371 $113,000
Q1 2020

May 14, 2020
BUY
$0.69 - $1.54 $16,705 - $37,284
24,211 Added 27.18%
113,273 $104,000
Q4 2019

Feb 14, 2020
SELL
$0.72 - $1.64 $11,378 - $25,916
-15,803 Reduced 15.07%
89,062 $141,000
Q3 2019

Nov 13, 2019
SELL
$0.64 - $0.92 $277,392 - $398,751
-433,425 Reduced 80.52%
104,865 $88,000
Q2 2019

Aug 13, 2019
SELL
$0.8 - $1.03 $23,546 - $30,315
-29,433 Reduced 5.18%
538,290 $463,000
Q1 2019

May 13, 2019
SELL
$0.9 - $1.37 $2,504 - $3,812
-2,783 Reduced 0.49%
567,723 $551,000
Q4 2018

Feb 12, 2019
SELL
$0.73 - $2.19 $205 - $615
-281 Reduced 0.05%
570,506 $418,000
Q3 2018

Nov 14, 2018
SELL
$1.72 - $5.24 $20,184 - $61,491
-11,735 Reduced 2.01%
570,787 $1.23 Million
Q2 2018

Sep 18, 2018
SELL
$3.81 - $5.26 $23,050 - $31,823
-6,050 Reduced 1.03%
582,522 $2.9 Million
Q2 2018

Aug 14, 2018
BUY
$3.81 - $5.26 $1.83 Million - $2.52 Million
479,548 Added 439.86%
588,572 $2.93 Million
Q1 2018

May 09, 2018
BUY
$2.7 - $4.06 $189,807 - $285,413
70,299 Added 181.53%
109,024 $425,000
Q3 2017

Nov 13, 2017
BUY
$3.12 - $3.65 $120,822 - $141,346
38,725
38,725 $123,000

About CTI BIOPHARMA CORP

CTIC Quotes by TradingView
  • Ticker CTIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 114,385,000
  • Market Cap $1.04B
  • Description
  • CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...
More about CTIC
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email